Efficacy of Enteral Nutrition within 24 Hours of Admission in Severe Acute Pancreatitis: a Meta-analysis

doi:10.12114/j.issn.1007-9572.2021.02.077

Chinese General Practice ›› 2022, Vol. 25 ›› Issue (24): 3057-3064.DOI: 10.12114/j.issn.1007-9572.2021.02.077

Special Issue: 胰腺炎最新文章合集；营养最新文章合集

• Evidence-based Medicine • Previous Articles Next Articles

Efficacy of Enteral Nutrition within 24 Hours of Admission in Severe Acute Pancreatitis: a Meta-analysis

¹Nantong Hospital Affiliated to Nanjing University of Chinese Medicine/Nantong Hospital of Traditional Chinese Medicine, Nantong 226000, China
²Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing 210000, China

Received:2021-10-13 Revised:2022-03-16 Published:2022-08-20 Online:2022-05-26
Contact: Guanwen GONG
About author:
WANG Q Q, ZHOU J, JIANG Z W, et al. Efficacy of enteral nutrition within 24 hours of admission in severe acute pancreatitis: a Meta-analysis[J]. Chinese General Practice, 2022, 25 (24) : 3057-3064.

入院24小时内肠内营养治疗重症急性胰腺炎疗效的Meta分析

¹226000　江苏省南通市，南京中医药大学南通附属医院　南通市中医院
²210000　江苏省南京市，南京中医药大学附属医院　江苏省中医院

通讯作者: 龚冠闻
作者简介:
王倩倩，周健，江志伟，等.入院24小时内肠内营养治疗重症急性胰腺炎疗效的Meta分析[J].中国全科医学，2022，25（24）：3057-3064. [www.chinagp.net] 作者贡献：王倩倩负责文章的构思与研究的设计、数据/资料收集和整理、论文撰写与修订；周健、江志伟负责整理数据，指导研究过程中出现的技术问题；龚冠闻负责研究的实施与可行性分析、文章的质量控制及审校，并对文章整体负责。
基金资助:
国家自然科学基金资助项目(81704083)

Abstract

Abstract:

Background

Enteral nutrition (EN) is one important clinical treatment for severe acute pancreatitis (SAP) , but the optimal timing of initiation remains controversial.

Objective

To evaluate the efficacy of EN within 24 hours of admission in the treatment of SAP by applying a Meta-analysis.

Methods

Databases of PubMed, EMBase, the Cochrane Library, Web of Science, CNKI, VIP, Wanfang Data and SinoMed were searched to identify randomized controlled trials (RCTs) about efficacies of usual care and EN within 24 hours of admission (experimental group) versus usual care in combination with EN or oral eating after 24 hours of admission or parenteral nutrition immediately after admission (control group) in SAP patients included from inception to July 2021. Meta-analysis was performed using RevMan 5.4 software.

Results

A total of 13 RCTs involving 1 193 patients were included. Meta-analysis results revealed that, compared to usual care with control interventions, usual care with EN within 24 hours of admission had better effects on reducing the mortality〔RR=0.61, 95%CI (0.39, 0.95) , P=0.03〕, incidence of multiple organ dysfunction syndrome (MODS) 〔RR=0.56, 95%CI (0.36, 0.86) , P=0.009〕and incidence of pancreatic infections〔RR=0.55, 95%CI (0.33, 0.91) , P=0.02〕, and post-treatment APACHE Ⅱ score〔MD=-2.18, 95%CI (-2.55, -1.80) , P<0.000 01〕. Further subgroup analysis indicated that, usual care with EN within 24 hours of admission was superior to usual care with parenteral nutrition immediately after admission in decreasing the mortality〔RR=0.28, 95%CI (0.11, 0.73) , P=0.009〕, incidence of MODS〔RR=0.40, 95%CI (0.20, 0.79) , P=0.009〕and pancreatic infections〔RR=0.50, 95%CI (0.25, 0.98) , P=0.04〕.

Conclusion

Available evidence showed that, EN within 24 hours of admission had better efficacy for SAP, and initiating EN within 24 hours of admission may be beneficial to the treatment of SAP.

Key words: Pancreatitis, Enteral nutrition, Parenteral nutrition, Severe acute pancreatitis, Meta-analysis, Systematic review, Randomized controlled trial

摘要：

背景

肠内营养是临床治疗重症急性胰腺炎（SAP）的重要手段之一，但其最佳启动时机尚存在争议。

目的

通过Meta分析方法评价入院24 h内肠内营养治疗SAP的疗效。

方法

计算机检索PubMed、EMBase、the Cochrane Library、Web of Science、中国知网、维普网、万方数据知识服务平台、中国生物医学文献服务系统，筛选关于入院24 h内肠内营养治疗SAP疗效的随机对照试验（RCT），检索时限均为建库至2021年7月。在常规治疗基础上，试验组患者入院24 h内进行肠内营养，对照组患者入院24 h后进行肠内营养或经口饮食，或入院后直接进行肠外营养。采用RevMan 5.4软件进行Meta分析。

结果

最终纳入13项RCT，包含1 193例患者。Meta分析结果显示，试验组患者病死率〔RR=0.61，95%CI（0.39，0.95），P=0.03〕、多器官功能障碍综合征（MODS）发生率〔RR=0.56，95%CI（0.36，0.86），P=0.009〕、胰腺感染发生率〔RR=0.55，95%CI（0.33，0.91），P=0.02〕、治疗后急性生理学及慢性健康状况评价系统Ⅱ（APACHE Ⅱ）评分〔MD=-2.18，95%CI（-2.55，-1.80），P<0.000 01〕低于对照组。亚组分析结果显示，对照组患者干预措施为入院后直接进行肠外营养时，试验组患者病死率〔RR=0.28，95%CI（0.11，0.73），P=0.009〕、MODS发生率〔RR=0.40，95%CI（0.20，0.79），P=0.009〕、胰腺感染发生率〔RR=0.50，95%CI（0.25，0.98），P=0.04〕低于对照组。

结论

当前研究证据表明入院24 h内肠内营养治疗SAP疗效较好，入院24 h内启动肠内营养对SAP的治疗是有益的。

关键词: 胰腺炎, 肠道营养, 胃肠外营养, 重症急性胰腺炎, Meta分析, 系统评价, 随机对照试验

Qianqian WANG,Jian ZHOU,Zhiwei JIANG, et al. Efficacy of Enteral Nutrition within 24 Hours of Admission in Severe Acute Pancreatitis: a Meta-analysis[J]. Chinese General Practice, 2022, 25(24): 3057-3064. DOI: 10.12114/j.issn.1007-9572.2021.02.077.
王倩倩,周健,江志伟等. 入院24小时内肠内营养治疗重症急性胰腺炎疗效的Meta分析[J]. 中国全科医学, 2022, 25(24): 3057-3064. DOI: 10.12114/j.issn.1007-9572.2021.02.077.

Figures/Tables 8

References 52

[1]	PORTELLI M，JONES C D. Severe acute pancreatitis：pathogenesis，diagnosis and surgical management[J]. Hepatobiliary Pancreat Dis Int，2017，16（2）：155-159. DOI：10.1016/s1499-3872(16)60163-7.
[2]	YASUDA H，HORIBE M，SANUI M，et al. Etiology and mortality in severe acute pancreatitis：a multicenter study in Japan[J]. Pancreatology，2020，20（3）：307-317. DOI：10.1016/j.pan.2020.03.001.
[3]	PENDHARKAR S A，MATHEW J，ZHAO J，et al. Ethnic and geographic variations in the incidence of pancreatitis and post-pancreatitis diabetes mellitus in New Zealand：a nationwide population-based study[J]. N Z Med J，2017，130（1450）：55-68.
[4]	SIREGAR G A，SIREGAR G P. Management of severe acute pancreatitis[J]. Open Access Maced J Med Sci，2019，7（19）：3319-3323. DOI：10.3889/oamjms.2019.720.
[5]	SARRI G，GUO Y，IHEANACHO I，et al. Moderately severe and severe acute pancreatitis：a systematic review of the outcomes in the USA and European Union-5[J]. BMJ Open Gastroenterol，2019，6（1）：e000248. DOI：10.1136/bmjgast-2018-000248.
[6]	RAMANATHAN M，AADAM A A. Nutrition management in acute pancreatitis[J]. Nutr Clin Prac，2019，34（Suppl 1）：S7-12. DOI：10.1002/ncp.10386.
[7]	MURPHY A E，CODNER P A. Acute pancreatitis：exploring nutrition implications[J]. Nutr Clin Pract，2020，35（5）：807-817. DOI：10.1002/ncp.10479.
[8]	BOXHOORN L，VOERMANS R P，BOUWENSE S A，et al. Acute pancreatitis[J]. Lancet，2020，396（10252）：726-734. DOI：10.1016/S0140-6736(20)31310-6.
[9]	CAPURSO G，ZERBONI G，SIGNORETTI M，et al. Role of the gut barrier in acute pancreatitis[J]. J Clin Gastroenterol，2012，46（Suppl）：S46-51. DOI：10.1097/MCG.0b013e3182652096.
[10]	LI X Y，HE C，ZHU Y，et al. Role of gut microbiota on intestinal barrier function in acute pancreatitis[J]. World J Gastroenterol，2020，26（18）：2187-2193. DOI：10.3748/wjg.v26.i18.2187.
[11]	CROCKETT S D，WANI S，GARDNER T B，et al. American Gastroenterological Association Institute guideline on initial management of acute pancreatitis[J]. Gastroenterology，2018，154（4）：1096-1101. DOI：10.1053/j.gastro.2018.01.032.
[12]	BANKS P A，BOLLEN T L，DERVENIS C，et al. Classification of acute pancreatitis—2012：revision of the Atlanta classification and definitions by international consensus[J]. Gut，2013，62（1）：102-111. DOI：10.1136/gutjnl-2012-302779.
[13]	GREENBERG J A，HSU J，BAWAZEER M，et al. Clinical practice guideline：management of acute pancreatitis[J]. Can J Surg，2016，59（2）：128-140. DOI：10.1503/cjs.015015.
[14]	HIGGINS J P T，THOMAS J，CHANDLER J，et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.1（updated September 2020）[EB/OL]. Cochrane，2020. [2021-09-07].
[15]	许健，秦侃，华剑，等. 肠内营养支持的不同时间对急性重症胰腺炎临床疗效的观察[J]. 中国药物评价，2018，35（2）：107-110. DOI：10.3969/j.issn.2095-3593.2018.02.008.
[16]	姚红兵，曾荣城，文明波，等. 早期肠内营养与延迟肠内营养治疗重症急性胰腺炎的临床疗效比较[J]. 实用医学杂志，2014，30（14）：2231-2233. DOI：10.3969/j.issn.1006-5725.2014.14.015.
[17]	王颖. 早期肠内营养治疗重症急性胰腺炎的临床疗效及安全性分析[J]. 中国现代药物应用，2021，15（4）：44-46. DOI：10.14164/j.cnki.cn11-5581/r.2021.04.016.
[18]	陈远忠，庞莉莉，郭健，等. 肠内营养治疗开始时间对重症急性胰腺炎患者临床疗效的影响[J]. 华中科技大学学报（医学版），2019，48（3）：329-333. DOI：10.3870/j.issn.1672-0741.2019.03.015.
[19]	WANG Y，YE H，ZHENG F，et al. Effects of micro-ecological enteral nutrition on systemic inflammatory response，bacterial translocation，and immune function in patients with severe acute pancreatitis[J]. Current Topics in Nutraceutical Research，2021，19（3）：240-248. DOI：10.37290/ctnr2641-452X.19:240-247.
[20]	STIMAC D，POROPAT G，HAUSER G，et al. Early nasojejunal tube feeding versus nil-by-mouth in acute pancreatitis：a randomized clinical trial[J]. Pancreatology，2016，16（4）：523-528. DOI：10.1016/j.pan.2016.04.003.
[21]	BAKKER O J，VAN BRUNSCHOT S，VAN SANTVOORT H C，et al. Early versus on-demand nasoenteric tube feeding in acute pancreatitis[J]. New Engl J Med，2014，371（21）：1983-1993. DOI：10.1056/NEJMoa1404393.
[22]	张弛. 不同营养支持模式对重症急性胰腺炎患者治疗效果的影响分析[J]. 中国实用医药，2020，15（1）：59-60. DOI：10.14163/j.cnki.11-5547/r.2020.01.026.
[23]	LOUIE B E，NOSEWORTHY T，HAILEY D，et al. 2004 MacLean-Mueller Prize enteral or parenteral nutrition for severe pancreatitis：a randomized controlled trial and health technology assessment[J]. Can J Surg，2005，48（4）：298-306.
[24]	ECKERWALL G E，AXELSSON J B，ANDERSSON R G. Early nasogastric feeding in predicted severe acute pancreatitis：a clinical，randomized study[J]. Ann Surg，2006，244（6）：959-967. DOI：10.1097/01.sla.0000246866.01930.58.
[25]	PETROV M S，KUKOSH M V，EMELYANOV N V. A randomized controlled trial of enteral versus parenteral feeding in patients with predicted severe acute pancreatitis shows a significant reduction in mortality and in infected pancreatic complications with total enteral nutrition[J]. Dig Surg，2006，23（5/6）：336-345. DOI：10.1159/000097949.
[26]	GUPTA R，PATEL K，CALDER P C，et al. A randomised clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic，inflammatory and oxidative markers in patients with predicted severe acute pancreatitis（APACHEⅡ> or =6）[J]. Pancreatology，2003，3（5）：406-413. DOI：10.1159/000073657.
[27]	刘广裕.早期肠内营养对重症急性胰腺炎患者的临床疗效[J]. 医疗装备，2016，29（13）：85-86. DOI：10.3969/j.issn.1002-2376.2016.13.058.
[28]	YAO H，HE C，DENG L，et al. Enteral versus parenteral nutrition in critically ill patients with severe pancreatitis：a meta-analysis[J]. Eur J Clin Nutr，2018，72（1）：66-68. DOI：10.1038/ejcn.2017.139.
[29]	QI D，YU B，HUANG J，et al. Meta-analysis of early enteral nutrition provided within 24 hours of admission on clinical outcomes in acute pancreatitis[J]. JPEN J Parenter Enteral Nutr，2018，42（7）：1139-1147. DOI：10.1002/jpen.1139.
[30]	OLÁH A，ROMICS L Jr. Enteral nutrition in acute pancreatitis：a review of the current evidence[J]. World J Gastroenterol，2014，20（43）：16123-16131. DOI：10.3748/wjg.v20.i43.16123.
[31]	YOKOE M，TAKADA T，MAYUMI T，et al. Japanese guidelines for the management of acute pancreatitis：Japanese Guidelines 2015[J]. J HepatobiliaryPancreat Sci，2015，22（6）：405-432. DOI：10.1002/jhbp.259.
[32]	NAKASHIMA I，HORIBE M，SANUI M，et al. Impact of enteral nutrition within 24 hours versus between 24 and 48 hours in patients with severe acute pancreatitis：a multicenter retrospective study[J]. Pancreas，2021，50（3）：371-377. DOI：0.1097/MPA.0000000000001768.
[33]	LI X，MA F，JIA K. Early enteral nutrition within 24 hours or between 24 and 72 hours for acute pancreatitis：evidence based on 12 RCTs[J]. Med Sci Monit，2014，20：2327-2335. DOI：10.12659/MSM.892770.
[34]	BAKKER O J，VAN BRUNSCHOT S，FARRE A，et al. Timing of enteral nutrition in acute pancreatitis：meta-analysis of individuals using a single-arm of randomised trials[J]. Pancreatology，2014，14（5）：340-346. DOI：10.1016/j.pan.2014.07.008.
[35]	VAUGHN V M，SHUSTER D，ROGERS M A M，et al. Early versus delayed feeding in patients with acute pancreatitis：a systematic review[J]. Ann Intern Med，2017，166（12）：883-892. DOI：10.7326/M16-2533.
[36]	ARVANITAKIS M，OCKENGA J，BEZMAREVIC M，et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis[J]. Clin Nutr，2020，39（3）：612-631. DOI：10.1016/j.clnu.2020.01.004.
[37]	中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南（2021）[J]. 中华外科杂志，2021，59（7）：578-587. DOI：10.3760/cma.j.cn112139-20210416-00172.
[38]	HUI L，ZANG K，WANG M，et al. Comparison of the preference of nutritional support for patients with severe acute pancreatitis[J]. Gastroenterol Nurs，2019，42（5）：411-416. DOI：10.1097/SGA.0000000000000331.
[39]	CHEN T，MA Y，XU L，et al. Soluble dietary fiber reduces feeding intolerance in severe acute pancreatitis：a randomized study[J]. JPEN J Parenter Enteral Nutr，2021，45（1）：125-135. DOI：10.1002/jpen.1816.
[40]	MAO E. Intensive management of severe acute pancreatitis[J]. Ann Transl Med，2019，7（22）：687. DOI：10.21037/atm.2019.10.58.
[41]	MCCLAVE S A，TAYLOR B E，MARTINDALE R G，et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient：Society of Critical Care Medicine（SCCM）and American Society for Parenteral and Enteral Nutrition（A.S.P.E.N.）[J]. JPEN J Parenter Enteral Nutr，2016，40（2）：159-211. DOI：10.1177/0148607115621863.
[42]	ECKERWALL G E，TINGSTEDT B B Å，BERGENZAUN P E，et al. Immediate oral feeding in patients with mild acute pancreatitis is safe and may accelerate recovery——a randomized clinical study[J]. Clin Nutr，2007，26（6）：758-763. DOI：10.1016/j.clnu.2007.04.007.
[43]	ZIEGLER T R，OGDEN L G，SINGLETON K D，et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients[J]. Intensive Care Med，2005，31（8）：1079-1086. DOI：10.1007/s00134-005-2690-5.
[44]	VAN SANTVOORT H C，BAKKER O J，BOLLEN T L，et al. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome[J]. Gastroenterology，2011，141（4）：1254-1263. DOI：10.1053/j.gastro.2011.06.073.
[45]	GUO Z Z，WANG P，YI Z H，et al. The crosstalk between gut inflammation and gastrointestinal disorders during acute pancreatitis[J]. Curr Pharm Des，2014，20（7）：1051-1062. DOI：10.2174/13816128113199990414.
[46]	TRUONG A，HANNA M H，MOGHADAMYEGHANEH Z，et al. Implications of preoperative hypoalbuminemia in colorectal surgery[J]. World J Gastrointest Surg，2016，8（5）：353-362. DOI：10.4240/wjgs.v8.i5.353.
[47]	ZHENG Z，DING Y X，QU Y X，et al. A narrative review of acute pancreatitis and its diagnosis，pathogenetic mechanism，and management[J]. Ann Transl Med，2021，9（1）：69. DOI：10.21037/atm-20-4802.
[48]	JABLONSKA B，MROWIEC S. Nutritional support in patients with severe acute pancreatitis——current standards[J]. Nutrients，2021，13（5）：1498. DOI：10.3390/nu13051498.
[49]	FAGHIH M，FAN C，SINGH V K. New advances in the treatment of acute pancreatitis[J]. Curr Treat Options Gastroenterol，2019，17（1）：146-160. DOI：10.1007/s11938-019-00223-8.
[50]	OSHIMA T，SINGER P，PICHARD C. Parenteral or enteral nutrition：do you have the choice？[J]. Curr Opin Crit Care，2016，22（4）：292-298. DOI：10.1097/MCC.0000000000000313.
[51]	ROBERTS K M，NAHIKIAN-NELMS M，UKLEJA A，et al. Nutritional aspects of acute pancreatitis[J]. Gastroenterol Clin North Am，2018，47（1）：77-94. DOI：10.1016/j.gtc.2017.10.002.
[52]	HONGYIN L，ZHU H，TAO W，et al. Abdominal paracentesis drainage improves tolerance of enteral nutrition in acute pancreatitis：a randomized controlled trial[J]. Scand J Gastroenterol，2017，52（4）：389-395. DOI：10.1080/00365521.2016.1276617.

序号	检索策略
#1	Randomized Controlled Trial[Publication Type]
#2	Controlled Clinical Trial[Publication Type]
#3	randomized[Title/Abstract]
#4	placebo[Title/Abstract]
#5	drug therapy[Subheading]
#6	randomly[Title/Abstract]
#7	trial[Title/Abstract]
#8	groups[Title/Abstract]
#9	OR #1-#8
#10	（Animals[Mesh]）NOT Humans[Mesh]
#11	#9 NOT #10
#12	Pancreatitis[Mesh]
# 13	severe acute pancreatitis[Title/Abstract]
#14	predicted severe acute pancreatitis[Title/Abstract]
#15	SAP[Title/Abstract]
#16	pSAP[Title/Abstract]
#17	acute severe pancreatitis[Title/Abstract]
#18	predicted acute severe pancreatitis[Title/Abstract]
#19	OR #12-#18
#20	Enteral Nutrition[Mesh]
#21	enteral nutrition[Title/Abstract]
#22	enteral feeding[Title/Abstract]
#23	tube feeding[Title/Abstract]
#24	artificial feeding[Title/Abstract]
#25	nasogastric[Title/Abstract]
#26	nasojejunal[Title/Abstract]
#27	OR #20-#26
#28	#19 And #27
#29	#11 And #28

序号	检索策略
#1	Randomized Controlled Trial[Publication Type]
#2	Controlled Clinical Trial[Publication Type]
#3	randomized[Title/Abstract]
#4	placebo[Title/Abstract]
#5	drug therapy[Subheading]
#6	randomly[Title/Abstract]
#7	trial[Title/Abstract]
#8	groups[Title/Abstract]
#9	OR #1-#8
#10	（Animals[Mesh]）NOT Humans[Mesh]
#11	#9 NOT #10
#12	Pancreatitis[Mesh]
# 13	severe acute pancreatitis[Title/Abstract]
#14	predicted severe acute pancreatitis[Title/Abstract]
#15	SAP[Title/Abstract]
#16	pSAP[Title/Abstract]
#17	acute severe pancreatitis[Title/Abstract]
#18	predicted acute severe pancreatitis[Title/Abstract]
#19	OR #12-#18
#20	Enteral Nutrition[Mesh]
#21	enteral nutrition[Title/Abstract]
#22	enteral feeding[Title/Abstract]
#23	tube feeding[Title/Abstract]
#24	artificial feeding[Title/Abstract]
#25	nasogastric[Title/Abstract]
#26	nasojejunal[Title/Abstract]
#27	OR #20-#26
#28	#19 And #27
#29	#11 And #28

第一作者	发表年份	例数（对照组/试验组）	性别（男/女）		年龄（岁）		干预措施		结局指标
第一作者	发表年份	例数（对照组/试验组）	对照组	试验组	对照组	试验组	对照组	试验组	结局指标
许健^[15]	2018	29/26	14/15	14/12	40.8±2.1	41.5±2.6	入院24~72 h给予鼻肠管营养	入院24 h内给予鼻肠管营养	①②
姚红兵^[16]	2014	32/32	17/15	18/14	35.2±5.5	35.8±6.2	入院48 h后给予鼻肠管营养	入院24 h内给予鼻肠管营养	④
王颖^[17]	2021	30/30	15/15	14/16	49.2±9.8	49.2±8.9	入院48 h后给予鼻肠管营养	入院24 h内给予鼻肠管营养	②④
陈远忠^[18]	2019	40/40	29/11	28/12	48.5±3.8	48.3±3.3	入院48 h后给予鼻肠管营养	入院24 h内给予鼻肠管营养	④
WANG^[19]	2021	63/64	40/23	38/26	47.3±9.9	46.4±9.7	入院72 h后给予鼻肠管营养	入院24 h内给予鼻肠管营养	④
STIMAC^[20]	2016	107/107	57/50	53/54	26.0~90.0	28.0~88.0	入院第3天给予经口饮食	入院24 h内给予鼻肠管营养	①②
BAKKER^[21]	2014	104/101	59/45	55/46	65.0±15.0	65.0±16.0	入院72 h后给予经口饮食	入院24 h内给予鼻肠管营养	①②③
张弛^[22]	2020	50/50	27/23	29/21	45.2±8.9	45.6±8.5	入院24 h内给予肠外营养	入院24 h内给予鼻肠管营养	②
LOUIE^[23]	2005	18/10	9/9	6/4	59.0±15.3	65.3±18.3	入院24 h内给予肠外营养	入院24 h内给予鼻肠管营养	①③
ECKERWALL^[24]	2006	25/23	—	—	60.0~80.0	58.0~80.0	入院24 h内给予肠外营养	入院24 h内给予鼻肠管营养	①②③
PETROV^[25]	2006	34/35	24/10	27/8	41.0~70.0	42.0~67.0	入院24 h内给予肠外营养	入院24 h内给予鼻肠管营养	①②③
GUPTA^[26]	2003	9/8	3/6	4/4	38.0~86.0	56.0~89.0	入院后直接进行肠外营养	入院24 h内给予鼻肠管营养	①
刘广裕^[27]	2016	63/63	—	—	44.2±0.7	42.5±1.9	入院后直接进行肠外营养	入院24 h内给予鼻肠管营养	①

第一作者	发表年份	例数（对照组/试验组）	性别（男/女）		年龄（岁）		干预措施		结局指标
第一作者	发表年份	例数（对照组/试验组）	对照组	试验组	对照组	试验组	对照组	试验组	结局指标
许健^[15]	2018	29/26	14/15	14/12	40.8±2.1	41.5±2.6	入院24~72 h给予鼻肠管营养	入院24 h内给予鼻肠管营养	①②
姚红兵^[16]	2014	32/32	17/15	18/14	35.2±5.5	35.8±6.2	入院48 h后给予鼻肠管营养	入院24 h内给予鼻肠管营养	④
王颖^[17]	2021	30/30	15/15	14/16	49.2±9.8	49.2±8.9	入院48 h后给予鼻肠管营养	入院24 h内给予鼻肠管营养	②④
陈远忠^[18]	2019	40/40	29/11	28/12	48.5±3.8	48.3±3.3	入院48 h后给予鼻肠管营养	入院24 h内给予鼻肠管营养	④
WANG^[19]	2021	63/64	40/23	38/26	47.3±9.9	46.4±9.7	入院72 h后给予鼻肠管营养	入院24 h内给予鼻肠管营养	④
STIMAC^[20]	2016	107/107	57/50	53/54	26.0~90.0	28.0~88.0	入院第3天给予经口饮食	入院24 h内给予鼻肠管营养	①②
BAKKER^[21]	2014	104/101	59/45	55/46	65.0±15.0	65.0±16.0	入院72 h后给予经口饮食	入院24 h内给予鼻肠管营养	①②③
张弛^[22]	2020	50/50	27/23	29/21	45.2±8.9	45.6±8.5	入院24 h内给予肠外营养	入院24 h内给予鼻肠管营养	②
LOUIE^[23]	2005	18/10	9/9	6/4	59.0±15.3	65.3±18.3	入院24 h内给予肠外营养	入院24 h内给予鼻肠管营养	①③
ECKERWALL^[24]	2006	25/23	—	—	60.0~80.0	58.0~80.0	入院24 h内给予肠外营养	入院24 h内给予鼻肠管营养	①②③
PETROV^[25]	2006	34/35	24/10	27/8	41.0~70.0	42.0~67.0	入院24 h内给予肠外营养	入院24 h内给予鼻肠管营养	①②③
GUPTA^[26]	2003	9/8	3/6	4/4	38.0~86.0	56.0~89.0	入院后直接进行肠外营养	入院24 h内给予鼻肠管营养	①
刘广裕^[27]	2016	63/63	—	—	44.2±0.7	42.5±1.9	入院后直接进行肠外营养	入院24 h内给予鼻肠管营养	①

第一作者	随机方法	结局测量者盲	患者盲、医生盲	分配隐藏	结果数据完整性	选择性报告研究结果	其他偏倚来源
许健^[15]	不清楚	不清楚	无	不清楚	完整	否	不清楚
姚红兵^[16]	不清楚	不清楚	无	不清楚	完整	否	不清楚
王颖^[17]	不清楚	不清楚	无	不清楚	完整	否	不清楚
陈远忠^[18]	不清楚	不清楚	无	不清楚	完整	否	不清楚
WANG^[19]	不清楚	不清楚	无	不清楚	完整	否	不清楚
STIMAC^[20]	计算机	不清楚	无	中心随机	完整	否	不清楚
BAKKER^[21]	计算机	是	无	中心随机	完整	否	不清楚
张弛^[22]	随机数字表	不清楚	无	不清楚	完整	否	不清楚
LOUIE^[23]	计算机	不清楚	无	密封信封	完整	否	不清楚
ECKERWALL^[24]	不清楚	无	无	密封信封	完整	否	不清楚
PETROV^[25]	计算机	不清楚	无	不清楚	完整	否	不清楚
GUPTA^[26]	不清楚	不清楚	无	密封信封	完整	否	Nutricia资助
刘广裕^[27]	就诊顺序	不清楚	无	不清楚	完整	否	不清楚

Efficacy of Enteral Nutrition within 24 Hours of Admission in Severe Acute Pancreatitis: a Meta-analysis

入院24小时内肠内营养治疗重症急性胰腺炎疗效的Meta分析

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 8

References 52

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	WANG Zhe, DONG Zhihao, ZHENG Hao, KONG Wencheng, ZHANG Yukuan, ZHANG Qiuyue, HAN Jing. Construction of Optimized Treatment Plan of Acupuncture for Migraine Based on Entropy Weight-TOPSIS Method [J]. Chinese General Practice, 2023, 26(34): 4336-4342.
[2]	WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335.
[3]	JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079.
[4]	JIA Yu, ZHOU Zitong, CAO Xuehua, HU Wanqin, XIANG Feng, XIONG Langyu, WANG Xiaoxia. Incidence of Perimenopausal Syndrome in Chinese Women Aged 40 to 65 Years: a Meta-analysis [J]. Chinese General Practice, 2023, 26(32): 4080-4088.
[5]	LI Jixin, QIU Linjie, REN Yan, WANG Wenru, LI Meijie, ZHANG Jin. The Correlation of Dietary Inflammatory Index with Overweight, Obesity and Abdominal Obesity: a Meta-analysis [J]. Chinese General Practice, 2023, 26(32): 4089-4097.
[6]	HE Jingyi, WANG Fang, SHUI Xiaoling, LI Ling, LIANG Qian. Efficacy of Non-pharmacological Interventions to Improve Perimenopausal Insomnia Symptoms: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(31): 3963-3974.
[7]	WANG Jiaxin, ZHAO Yali. Domestic and International Assessment Tools for Medical Teamwork: a Systematic Review [J]. Chinese General Practice, 2023, 26(31): 3951-3962.
[8]	QU Hui, LI Huan, TANG Ruohan, DU Yuzheng, ZHAO Qi. Outcome Indicators Analysis of Randomized Controlled Trials of Acupuncture for Obstructive Sleep Apnea Hypopnea Syndrome in the Past Decade [J]. Chinese General Practice, 2023, 26(30): 3734-3739.
[9]	ZHU Lin, GUO Yankui, GAO Chen, CHEN Xuezhi, WANG Fashuai. Efficacy of Western Medicine, Chinese Patent Medicine and Their Combination on Post-stroke Insomnia: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3823-3832.
[10]	ZHANG Dongli, SHEN Chong, ZHANG Weichuan, CHEN Haibin, ZHAO Jianjun. Efficacy and Safety of Programmed Death-1/Programmed Death-1 Ligand Inhibitors in the Treatment of Renal Cell Cancer: a Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3815-3822.
[11]	HE Li, ZHANG Yifan, SHEN Xuechun, SUN Yan, ZHAO Yang. Prevalence Trends of Multimorbidity among Residents in Mainland China: a Meta-analysis [J]. Chinese General Practice, 2023, 26(29): 3599-3607.
[12]	REN Yanfeng, LIU Shimeng, TAO Ying, CHEN Yingyao. A Systematic Review of Medication Preferences for Patients with Depression Based on Discrete Choice Experiment and Best-worst Scaling [J]. Chinese General Practice, 2023, 26(28): 3559-3564.
[13]	Expert group of expert consensus on the application of ulinastatin in common clinical critical illness. Expert Consensus on the Application of Ulinastatin in Common Clinical Critical Illness [J]. Chinese General Practice, 2023, 26(26): 3207-3219.
[14]	LIN Yang, WANG Fang, WANG Han, WU Rong, WANG Yao, XU Ziyao, WANG Xu, WANG Yanding. Prevalence of Frailty in Elderly Patients with Comorbidity: a Meta-analysis [J]. Chinese General Practice, 2023, 26(25): 3185-3193.
[15]	DUAN Yuxia, LI Zhen, ZHANG Siqi, FANG Zhixue, QIN Yuelan. Effect of Patient Decision Aids in the Diagnosis and Treatment of Colorectal Cancer: a Systematic Review [J]. Chinese General Practice, 2023, 26(25): 3194-3201.